LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Laboratory Corp of America Holdings

Geschlossen

BrancheGesundheitswesen

253.76 0.4

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

250.54

Max

253.88

Schlüsselkennzahlen

By Trading Economics

Einkommen

69M

213M

Verkäufe

16M

3.3B

KGV

Branchendurchschnitt

28.587

51.198

EPS

3.84

Dividendenrendite

1.16

Gewinnspanne

6.368

Angestellte

60,900

EBITDA

80M

498M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+9.1% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.16%

2.40%

Nächstes Ergebnis

31. Juli 2025

Nächste Dividendenausschüttung

11. Juni 2025

Nächstes Ex-Dividendendatum

28. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

1.5B

21B

Vorheriger Eröffnungskurs

253.36

Vorheriger Schlusskurs

253.76

Nachrichtenstimmung

By Acuity

50%

50%

166 / 380 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Laboratory Corp of America Holdings Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Mai 2025, 18:12 UTC

Ergebnisse

Netflix Is Eating Disney's Lunch. How to Bring Back the Magic. -- Barrons.com

Peer-Vergleich

Kursveränderung

Laboratory Corp of America Holdings Prognose

Kursziel

By TipRanks

9.1% Vorteil

12-Monats-Prognose

Durchschnitt 275.09 USD  9.1%

Hoch 291 USD

Tief 250 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Laboratory Corp of America Holdings – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

12 ratings

10

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

196.14 / 197.94Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

166 / 380 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.